Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-23-102090
Filing Date
2023-04-14
Accepted
2023-04-14 16:15:50
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d479088ddefa14a.htm DEFA14A 11660
2 GRAPHIC g479088dsp003.jpg GRAPHIC 283209
3 GRAPHIC g479088dsp004.jpg GRAPHIC 233220
  Complete submission text file 0001193125-23-102090.txt   724203
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33137 | Film No.: 23821341
SIC: 2834 Pharmaceutical Preparations